GSK Plc (GSK)
50.56
+0.32
(+0.63%)
USD |
NYSE |
Sep 01, 12:17
GSK Cash from Operations (Annual) : 9.625B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 9.625B |
| December 31, 2024 | 7.783B |
| December 31, 2023 | 7.891B |
| December 31, 2022 | 8.161B |
| December 31, 2021 | 9.906B |
| December 31, 2020 | 9.806B |
| December 31, 2019 | 9.203B |
| December 31, 2018 | 10.36B |
| December 31, 2017 | 7.994B |
| December 31, 2016 | 7.906B |
| December 31, 2015 | 2.920B |
| December 31, 2014 | 7.470B |
| December 31, 2013 | 10.26B |
| December 31, 2012 | 5.819B |
| December 31, 2011 | 8.982B |
| December 31, 2010 | 9.488B |
| December 31, 2009 | 11.25B |
| December 31, 2008 | 12.53B |
| Date | Value |
|---|---|
| December 31, 2007 | 12.09B |
| December 31, 2006 | 7.836B |
| December 31, 2005 | 10.68B |
| December 31, 2004 | 8.750B |
| December 31, 2003 | 8.098B |
| December 31, 2002 | 8.242B |
| December 31, 2001 | 6.806B |
| December 31, 2000 | 6.097B |
| December 31, 1999 | 5.775B |
| December 31, 1998 | 2.774B |
| December 31, 1997 | 2.999B |
| December 31, 1996 | 2.947B |
| December 31, 1995 | 4.383B |
| June 30, 1994 | 2.443B |
| June 30, 1993 | 2.364B |
| June 30, 1992 | 1.958B |
| June 30, 1991 | 1.752B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AstraZeneca PLC | 14.90B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Pfizer Inc. | 11.70B |
| Sanofi | 12.13B |